July 2016—Protagen gained CE marking for its Multilisa BICD2 test. BICD2 is a proprietary biomarker discovered by Protagen using the SeroTag technology platform.
Read More »Home >> Tag Archives: Protagen
Protagen, Qiagen agreement, 2/15
February 2014—Protagen has entered into a long-term collaboration agreement with Qiagen to target the development of novel protein-based companion diagnostics for autoimmune disorders. Under the terms of the agreement, Qiagen will gain access to Protagen’s proprietary SeroTag technology platform, which enables the discovery and validation of novel protein-based marker panels.
Read More »ELISA test kit for systemic sclerosis, 10/14
October 2014—Protagen launched its first ELISA research-use test kit, the ADxSSc Multilisa, for systemic sclerosis.
Read More »